Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
CEVA Inc
CEVA
$855M
| $5.86M | 0.01% |
165,000
-9,700
| -6% | -$335K |
|
|
TESS
1577
DELISTED
Tessco Technologies Inc
TESS
| $5.85M | 0.01% |
372,748
-5,752
| -2% | -$81.3K |
|
1578
Sturm, Ruger & Co
RGR
$601M
| $5.84M | 0.01% |
109,100
-164,900
| -60% | -$8.47M |
|
|
LAYN
1579
DELISTED
Layne Christensen Co
LAYN
| $5.84M | 0.01% |
660,200
-33,854
| -5% | -$332K |
|
|
HBP
1580
DELISTED
Huttig Building Products, Inc.
HBP
| $5.83M | 0.01% |
716,477
+148,177
| +26% | +$1.05M |
|
1581
Enovis
ENOV
$1.48B
| $5.83M | 0.01% |
+86,279
| New | +$5.75M |
|
|
LMIA
1582
DELISTED
LMI Aerospace Inc
LMIA
| $5.83M | 0.01% |
423,000
+58,200
| +16% | +$658K |
|
|
PAMT
1583
PAMT Corp
PAMT
$285M
| $5.82M | 0.01% |
1,429,600
-26,000
| -2% | -$135K |
|
|
OMCC
1584
DELISTED
Old Market Capital Corp
OMCC
| $5.79M | 0.01% |
544,829
+3,600
| +0.7% | +$39.6K |
|
|
MBTF
1585
DELISTED
MBT Financial Corporation
MBTF
| $5.78M | 0.01% |
509,447
-65,267
| -11% | -$719K |
|
1586
OneSpan
OSPN
$624M
| $5.76M | 0.01% |
426,900
-55,400
| -11% | -$778K |
|
|
TGB
1587
Trekor Metals
TGB
$3.08B
| $5.75M | 0.01% |
4,354,600
+1,216,700
| +39% | +$1.6M |
|
|
EPAY
1588
DELISTED
Bottomline Technologies Inc
EPAY
| $5.75M | 0.01% |
243,142
-55,200
| -19% | -$1.39M |
|
1589
KB Financial Group
KB
$41.7B
| $5.75M | 0.01% |
130,700
-67,200
| -34% | -$2.77M |
|
1590
HubSpot
HUBS
$12B
| $5.75M | 0.01% |
+94,900
| New | +$5.38M |
|
|
CIM
1591
Chimera Investment
CIM
$993M
| $5.74M | 0.01% |
94,887
-122,900
| -56% | -$6.85M |
|
|
CARO
1592
DELISTED
Carolina Financial Corp.
CARO
| $5.73M | 0.01% |
191,100
+41,400
| +28% | +$1.25M |
|
1593
Rocky Mountain Chocolate Factory
RMCF
$15.6M
| $5.73M | 0.01% |
508,070
+19,885
| +4% | +$220K |
|
|
CO
1594
DELISTED
Global Cord Blood Corporation
CO
| $5.72M | 0.01% |
859,500
+52,700
| +7% | +$312K |
|
1595
IMAX
IMAX
$2.92B
| $5.72M | 0.01% |
168,320
+98,420
| +141% | +$3.21M |
|
|
IMGN
1596
DELISTED
Immunogen Inc
IMGN
| $5.72M | 0.01% |
1,477,946
-1,003,794
| -40% | -$2.93M |
|
1597
Banner Corp
BANR
$2.5B
| $5.71M | 0.01% |
102,669
+59,278
| +137% | +$3.39M |
|
1598
Stride
LRN
$3.48B
| $5.7M | 0.01% |
297,700
-500
| -0.2% | -$9.05K |
|
|
RNWK
1599
DELISTED
RealNetworks Inc
RNWK
| $5.7M | 0.01% |
1,177,678
+19,300
| +2% | +$95.6K |
|
|
WMC
1600
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $5.68M | 0.01% |
58,191
+7,221
| +14% | +$730K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.